Format

Send to

Choose Destination
Nat Biotechnol. 2005 Sep;23(9):1054-8.

Flexibility--the guiding principle for antibody manufacturing.

Author information

1
The Williamsburg BioProcessing Foundation, Foundation PO Box 1229, 1206 Laskin Road, Suite 201, Virginia Beach, Virginia 23451, USA. kcarson@wilbio.com

Abstract

Ensuring adequate manufacturing capacity for recombinant and monoclonal antibodies is one of the greatest challenges facing the biotech industry. The following factors should be taken into account when designing product development and production strategies.

PMID:
16151390
DOI:
10.1038/nbt0905-1054
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center